Enovix Co. (NASDAQ:ENVX – Get Free Report) shares were up 6.2% during trading on Monday . The stock traded as high as $9.93 and last traded at $9.82. Approximately 1,188,132 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 5,556,333 shares. The stock had previously closed at $9.25.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. dropped their target price on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Oppenheimer reissued an “outperform” rating and set a $36.00 target price on shares of Enovix in a research note on Monday, August 26th. Benchmark reaffirmed a “buy” rating and issued a $25.00 target price on shares of Enovix in a research report on Wednesday, October 30th. Janney Montgomery Scott downgraded Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective for the company. in a research note on Thursday, October 31st. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $19.00 target price (down previously from $23.00) on shares of Enovix in a research note on Monday, August 5th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $20.50.
Read Our Latest Report on ENVX
Enovix Stock Performance
Enovix (NASDAQ:ENVX – Get Free Report) last announced its earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.03. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. The firm had revenue of $4.30 million during the quarter, compared to analysts’ expectations of $4.11 million. During the same quarter in the prior year, the business earned ($0.27) earnings per share. On average, research analysts predict that Enovix Co. will post -1.17 EPS for the current year.
Insider Buying and Selling
In other news, insider Arthi Chakravarthy sold 35,000 shares of the firm’s stock in a transaction on Monday, October 14th. The shares were sold at an average price of $13.00, for a total value of $455,000.00. Following the sale, the insider now owns 343,305 shares in the company, valued at approximately $4,462,965. This trade represents a 9.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 15.70% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of ENVX. Arizona State Retirement System increased its stake in Enovix by 2.3% in the second quarter. Arizona State Retirement System now owns 40,097 shares of the company’s stock valued at $620,000 after acquiring an additional 905 shares during the period. Blue Trust Inc. grew its stake in shares of Enovix by 102.1% in the 2nd quarter. Blue Trust Inc. now owns 1,894 shares of the company’s stock valued at $29,000 after purchasing an additional 957 shares during the period. Voisard Asset Management Group Inc. raised its holdings in shares of Enovix by 25.0% in the 2nd quarter. Voisard Asset Management Group Inc. now owns 5,000 shares of the company’s stock worth $77,000 after buying an additional 1,000 shares in the last quarter. Rockefeller Capital Management L.P. lifted its position in shares of Enovix by 6.7% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 21,656 shares of the company’s stock worth $202,000 after buying an additional 1,367 shares during the period. Finally, Clear Creek Financial Management LLC boosted its stake in Enovix by 3.0% in the 3rd quarter. Clear Creek Financial Management LLC now owns 48,200 shares of the company’s stock valued at $450,000 after buying an additional 1,400 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Recommended Stories
- Five stocks we like better than Enovix
- What is Insider Trading? What You Can Learn from Insider Trading
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Industrial Products Stocks Investing
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
- How to Use the MarketBeat Dividend Calculator
- 4 AI-Powered Fintechs Revolutionizing the Future of Finance
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.